Physician profile
James E Logan
NPI 1952363962
$5,759.76
in general payments reported to CMS, 2019-2025
42 companies · $1,110 in 2025
The $1,110 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $789 · 2020: $473 · 2021: $548 · 2022: $1,023 · 2023: $788 · 2024: $1,027 · 2025: $1,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,925.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $932.52 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $719.90 | 2019-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals Lp | $592.69 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $424.24 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Abbvie INC. | $385.80 | 2020-2025 | |
| Glaxosmithkline, LLC. | $262.18 | 2019-2025 | Shingrix, Trelegy Ellipta, Bexsero |
| Pfizer INC. | $242.76 | 2019-2025 | |
| Sanofi Pasteur INC. | $230.57 | 2019-2025 | |
| Abbott Laboratories | $197.11 | 2021-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $155.70 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $154.56 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $150.25 | 2019-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.90 | 2019-2024 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $110.45 | 2021-2023 | Xarelto |
| Sumitomo Pharma America, INC. | $87.37 | 2023-2025 | Gemtesa |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.